Akebia Therapeutics (AKBA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful ...

List today: Pharming Group N.V. PHAR: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current ...

Inflation, tariffs, and trade wars have investors seeking resilient investments. Click here to learn about 5 top stocks.

With the summer of 2025 in full swing, all eyes are once again on President Trump’s trade moves. Over the past week, Trump ...

IDEXX Laboratories benefits from strong pet care trends, new platform adoption, and a high-margin recurring model that drives ...

These five top Buy-rated dividend stocks were among S&P 500's top performers so far this year and still offer strong total ...

With potentially higher tariffs and interest rates back in the news, growth stocks will likely take a hit in the short term.

Hagerty, Inc. (HGTY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Indeed, AMZN isn’t just a run-of-the-mill strong buy tech stocks. Rather, it’s a unanimous strong buy based on 29 analysts. Overall, their average price target lands at $152.52, implying ...

We used Finviz and Tipranks to make a list of 35 strong buy stocks. We then selected the top 10 stocks with the highest analyst upside potential as of March 12, 2025.